High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.8M
$2,784,238
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CYTK |
CYTOKINETICS INC
|
CEO
Sell to Cover
|
2026-03-09 | $481,570 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-09
$156,779
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-09 | $156,779 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Sell to Cover
2026-03-09
$176,513
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Sell to Cover
|
2026-03-09 | $176,513 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-03-05
$779,330x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-03-05 | $779,330x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
2026-03-05
$1,608,730Largex2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
|
2026-03-05 | $1,608,730Largex2 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-03-02
$33,340
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-03-02 | $33,340 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-03-02
$54,595
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-02 | $54,595 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -21.8%
|
2026-03-02 | $306,050 | S | Form 4 |